Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 4 1Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Tobacco Use Disorder 1Tobacco Use Cessation 1Smoking Cessation 1Neoplasms 1Lung Neoplasms 1

Interventions

Paclitaxel 20Gemcitabine 16Dexamethasone 16Bevacizumab 16Docetaxel 15Oxaliplatin 14Cyclophosphamide 13Carboplatin 12Capecitabine 12Sorafenib 11Fluorouracil 11Leucovorin 10Cisplatin 10pembrolizumab 9Prednisone 9Pemetrexed 9Epoetin Alfa 9venetoclax 8atezolizumab 8Fentanyl 8Drug Therapy 8Doxorubicin 8Rivaroxaban 7Rituximab 7Darbepoetin alfa 7Anastrozole 7Panitumumab 6Ondansetron 6Morphine 6Irinotecan 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Neoplasms × Varenicline × Clear all
NCT01756885 2019-07-30

Extended Varenicline Treatment for Smoking Among Cancer Patients

University of Pennsylvania

Phase 3 Completed
207 enrolled 17 charts

Neoplasms, Tobacco Use Disorder, Smoking Cessation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡